Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats

International Journal of Neuroscience

Volumn 122, Issue 10, 2012, Pages 611-617

  Zhao, Wei Jiang ^a,b   Wu, Chonghou ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bloodbrain barrier (BBB); Cerebral vasospasm; Nimodipine (NDP); Rats; Regional blood flow (rCBF); Subarachnoid hemorrhage (SAH)

Indexed keywords

EVANS BLUE; NIMODIPINE; SODIUM CHLORIDE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DYSFUNCTION; BRAIN VASOSPASM; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; CISTERNA MAGNA; CONTROLLED STUDY; EXTRAVASATION; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; OUTCOME ASSESSMENT; RAT; SUBARACHNOID HEMORRHAGE; TREATMENT RESPONSE; VERTEBRAL ARTERY;

ANIMALS; BLOOD-BRAIN BARRIER; CEREBROVASCULAR CIRCULATION; CISTERNA MAGNA; DISEASE MODELS, ANIMAL; MALE; NIMODIPINE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84866401636     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.700661     Document Type: Article

References (32)

1. Huang J, Van Gelder JM. The probability of sudden death from rupture of ntracranial aneurysms: A meta-analysis. Neurosurgery 2002;51:1101-7.
2. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25:1342-7.
3. Sun BL, Zhang SM, Xia ZL, Yang MF, Yuan H, Zhang J, Xiu RJ. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage. Clin Hemorheol Microcirc. 2003;29:337-44.
4. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, Zhang JH. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke. 2004;35:1-6.
5. Germanò A, Costa C, DeFord SM, Angileri FF, Arcadi F, Pike BR, Bramanti P, Bausano B, Zhao X, Day AL, Anderson DK, Hayes RL. Systemic administration of a calpain inhibitor reduces behavioral deficits and boold-brain-barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J. Neurotrauma 2002;19,:887-96.
6. Castanares-Zapatero D, Hantson P. Pharmacological, treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage. Ann Intensive Care. 2011;1:12.
7. Wei EP, Lamb RG, Kontos HA. Increased phospholipase C activity after experimental brain injury. J Neurosurg. 1982;56:695-8.
8. Zornow MH, Prough S. Neuroprotective properties of calciumchannel blockers. New Horiz. 1996; 4:107-14.
9. Grotenhuis JA, Bettag W, Fiebach BJ, Dabir K. Intracarotid slow bolus injection of nimodpine during angiography for treatment of cerebral vasospasm after SAH. J Neurosurg. 1984;61: 231-40.
10. Watanabe H, Clozel M, Clozel JP. Nimodipine does not increase cerebral blood flow during subarachnoid hemorrhage in the rat. Pharmacology 1996; 53:1-10.
11. van Gijn J, Kerr, RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet, 2007;369: 306-18.
12. Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: Review of randomized controlled trials and meta-analyses in the literature. World Neurosurg, 2011;76: 446-54.
13. Germanò A, d'Avella D, Imperatore C, Caruso G, Tomasello F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 2000;142:575-81.
14. Prunell GF, Mathiesen T, Svendgaard NA. Experimental subarachnoid hemorrhage:cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery. 2004;54:426-37.
15. Germanò A, Imperatore C, d'Avella D, Costa G, Tomasello F. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurg. 1998;88:1075-81.
16. Longo M, Blandino A, Ascenti G, Ricciardi GK, Granata F, Vinci S. Cerebral angiography in the rat with mammographic equipment: A simple, cost-effective method for assessing vasospasm in experimental subarachnoid hemorrhage. Neuroradiol. 2002;44:689-94.
17. Smith SL, Scherch HM, Hall ED. Protective effects of tirilazad mesylate and metabolite U-89678 against bloodbrain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J Neurosurg. 1996;84:229-
18. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL 3rd, Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery. 1998;42:352-62.
19. Dreier JP, Windm uller O, Petzold G, Lindauer U, Einhaupl KM, Dirnagl U. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilusion in rats. Neurosurgery. 2002;51:1457-67.
20. Soustiel JF, Shik V, Shreiber R, Tavor Y, Goldsher D. Basilar vasospasm diagnosis investigation of a modified "lindergaard index" based on imaging studies and blood velocity measurements of the basilar artery. Stroke. 2002;33:72-8.
21. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurismal subarachnoid hemorrhage. Stroke. 2000; 31:1621-7.
22. SviriGE, LewisDH, Correa R, BritzGW, Douville CM, Newell DW. Basilar artery vasospsm and delayed posterior circulation ischemia after aneurismal subarachnoid hemorrhge. Stroke. 2004;35:1867-72.
23. Ono S, Date I, Nakajima M, Onoda K, Ogihara K, Shiota T, Asari S, Ninomiya Y, Yabuno N, Ohmoto T. Threedimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique. Stroke. 1997; 28 1631-8.
24. Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998;29:2155-61.
25. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol Toxicol 1985;25:593-620.
26. Taylor DA, Stull JT. Calcium dependence of myosin light chain phosphorylation in smooth muscle cells. J Biol. 1988;28:14456-62.
27. Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH. Upregulation of Rho A and Rho kinase messenger RNAs in the basilar artery of a ratmodel of subarachnoid hemorrhage. J Neurosurg. 2000; 93: 471-6.
28. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of Rhokinase- mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000;87:195-200.
29. Hanggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Nawatny J, Turowski B, Sommer C, Steiger HJ. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. Neurosurgery. 2009;64:1155-9; discussion 1159-61.
30. Johshita H, Kassell NF, Sasaki T. Blood-brain barrier disturbance following subarachnoid hemorrhage in rabbits. Stroke. 1990;21:1051-8.
31. Chen LH, Liu LX, Yang YJ, Liu YS, Cao MH. Neuroprotective effects of nimodpine and MK-801 on acute infectious brain edema by injection of pertussis bacilli to neocortex of rats. Chin J Traumatol. 2003;6:118-23.
32. Stiefel MF, Heuer GG, Abrahams JM, Bloom S, Smith MJ, Maloney-Wilensky E, Grady MS, LeRoux PD. The effects of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage. J Neurosurg. 2004;101:594-9.